Group Finance Business Insights Director – Rare Disease

AstraZeneca; Dublin; On-site; EUR 125,000 - 150,000; Full time

Job summary

A leading pharmaceutical company in Dublin is seeking a qualified Group Insights Director to enhance decision-making through insightful financial analysis within their Rare Disease sector. Ideal candidates will possess significant finance qualifications (ACA/ACCA/CIMA/MBA), strong analytical and communication skills, and experience in commercial finance. The role requires building influential relationships and presenting to senior stakeholders, while driving performance through solid strategic planning. This position offers a chance to impact the organization significantly, with a deadline for applications on February 1, 2026.

Qualifications

• Experienced and analytical finance professional able to create high-impact materials for senior audiences.
• Proactive, delivery-focused, and energetic in a dynamic environment.
• Excellent in building relationships and engaging stakeholders.

Responsibilities

• Drive and shape AstraZeneca's commercial performance.
• Act as the authority for the Rare Disease business within Group Finance.
• Prepare strategic targets and manage key performance forecasts.

Skills

Analytical skills

Communication skills

Influencing skills

Networking

Education

Relevant Finance/Business qualification (e.g., ACA/ACCA/CIMA/MBA)

Excellent academic record

Tools

Microsoft Excel

PowerPoint

Hyperion Planning

Job description

Are you a qualified finance professional with experience of enterprise planning and reporting? Do you have a track record of delivering change? As best in class finance support becomes ever more important, this role offers you the chance to work as part of the Group Planning and Business Performance team based in Cambridge.

About AstraZeneca

At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person.

What you’ll do

As the Group Insights Director you will play a key a key role in Group reporting and planning processes, driving central understanding and insight on our Rare Disease business to inform decision making and target setting on this critical area of the business. This role offers the chance to add real business value through enhanced commercial insight, and the opportunity to build strong and wide-ranging networks within Group and Commercial Finance functions.

We are looking for a candidate with relevant expertise and experience, but more importantly a problem solver, simplifier, integrator, connector and communicator. A change agent who challenges, is curious, works with an agile, positive mindset, and has the ability to think differently and make it happen.

Responsibilities

The role reports to the Head of Group Insights Finance Director and will primarily be responsible for:

• Providing insight, expertise and analysis to help drive and shape the commercial performance of AstraZeneca
• Being the authority for the Rare Disease business within the Group Finance team, acting as the link between the commercial unit and the Group function across all planning and reporting cycles
• Proactively identifying, collating and analysing a range of financial and non-financial data to develop a deep understanding of the drivers of performance and key emerging trends impacting our Rare Disease business
• Ensuring that key planning assumptions and drivers of performance are understood, bringing constructive challenge to forecasts, planning assumptions and resource allocation based on credible insights, intelligence & analysis
• Preparing stretched but attainable targets that align to the Enterprise’s strategic and financial objectives
• Developing an understanding of the 10 year Rare Disease Long Term Plan, including a view on pipeline assets and potential
• Handling a range of other ad-hoc requests in support of the CEO and SET/Board reporting
• Identifying and acting on continuous improvement and digitization opportunities in GFP&A processes, performance and reporting

Education, Qualifications, Skills and Experience

Essential for the role

• Experienced and analytical Finance professional with the ability to deliver succinct, high impact briefing material suitable for SET / Board level audiences
• Finance/Business qualification e.g. Qualified ACA/ACCA/CIMA/MBA
• Excellent academic record
• Curious, proactive and delivery focused, comfortable working in a dynamic, challenging environment
• Energetic, resilient and tenacious
• Excellent influencing and communication skills with the confidence to engage senior stakeholders and ability to drive bigger picture thinking
• Good networking and relationship building skills

Desirable for the role

• Experience of Commercial Finance and/or Group FP&A, preferably within a large pharmaceutical business
• Strong systems skills; advanced Microsoft Excel & PowerPoint, knowledge of Hyperion Planning would also be advantageous

Date Posted

05-Jan-2026

Closing Date

01-Feb-2026

Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.